Kantos Master Nexthaler (Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous)

Beclometasone dipropionate activates glucocorticoid receptors in airway cells, suppressing inflammatory mediators and reducing swelling. Formoterol fumarate binds to β2‑adrenergic receptors on bronchial smooth muscle, increasing cyclic AMP and causing sustained relaxation of the airways. Together they provide anti‑inflammatory and bronchodilatory effects.

The prescribed dose of Kantos Master Nexthaler is determined by a healthcare professional based on the individual’s disease severity, age, and response to therapy. Typical regimens involve inhaling a specific number of doses twice daily, but the exact schedule should always follow the prescriber’s instructions.

Safety data for beclometasone dipropionate / formoterol fumarate in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Pregnant or nursing patients should discuss use with their healthcare provider.

To order Kantos Master Nexthaler, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Kantos Master Nexthaler contains beclometasone dipropionate and formoterol fumarate, a combination similar in class to budesonide/formoterol or fluticasone/salmeterol. All provide anti‑inflammatory and bronchodilator actions, but differences exist in potency, onset of action, device design and regulatory approvals. Choice depends on clinical response, patient preference and formulary considerations.

Store Kantos Master Nexthaler at ambient temperature, below 25 °C, in its original packaging. Protect the device from moisture, direct sunlight and extreme heat. Keep the inhaler out of reach of children and do not expose it to freezing conditions.

The medication is delivered via a dry‑powder Nexthaler device. The patient should exhale fully away from the inhaler, place the mouthpiece in the mouth, seal lips, and inhale sharply and deeply. After inhalation, hold the breath for a few seconds before exhaling. The device should be primed according to the manufacturer’s instructions before first use.

Serious adverse reactions, although rare, include paradoxical bronchospasm, adrenal suppression leading to systemic corticosteroid effects, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience sudden worsening of breathing, signs of infection, or any symptoms of a severe allergic response.

Kantos Master Nexthaler is contraindicated in individuals with known hypersensitivity to beclometasone